Skip to Content
MilliporeSigma
All Photos(1)

Key Documents

1.06839

Supelco

Sodalime pellets with indicator

for analysis

Sign Into View Organizational & Contract Pricing


About This Item

UNSPSC Code:
12352319
NACRES:
NB.21

Pricing and availability is not currently available.

Quality Level

loss

13.0 - 18.0% loss on drying, (105°C)

color

, Passes test

particle size

2-5 mm, coeff var ≥95%

capacity

≥25 % absorption capacity (CO2)((method NF XVII))

bulk density

75 g/100 mL

suitability

passes test

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
1.931031.067331.04764
Sodalime with indicator, granules ~ 1 - 2.5 mm

1.06733

Sodalime

particle size

2-5 mm, coeff var ≥95%

particle size

-

particle size

1-2.5 mm

particle size

-

Quality Level

200

Quality Level

-

Quality Level

200

Quality Level

200

bulk density

75 g/100 mL

bulk density

-

bulk density

750 kg/m3

bulk density

-

loss

13.0 - 18.0% loss on drying, (105°C)

loss

-

loss

-

loss

-

color

, Passes test

color

-

color

-

color

-

capacity

≥25 % absorption capacity (CO2)((method NF XVII))

capacity

-

capacity

-

capacity

-

pictograms

CorrosionExclamation mark

signalword

Danger

Hazard Classifications

Eye Dam. 1 - Met. Corr. 1 - Skin Corr. 1 - STOT SE 3

target_organs

Respiratory system

Storage Class

8B - Non-combustible, corrosive hazardous materials

wgk_germany

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Need A Sample COA?

This is a sample Certificate of Analysis (COA) and may not represent a recently manufactured lot of this specific product.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Karsten Weller et al.
Acta dermato-venereologica, 93(2), 168-174 (2012-10-12)
Non-sedating H1-antihistamines are the recommended first-line treatment for chronic spontaneous urticaria. While efficacy studies usually apply continuous daily treatment regimens, many patients take their medication on demand. In this randomized, double-blind trial we tested whether on-demand H1-antihistamine desloratadine in standard
P Deep et al.
Synapse (New York, N.Y.), 34(4), 313-318 (1999-10-26)
The efficacy of amantadine in alleviating motor symptoms of Parkinson's disease may be mediated in part by stimulation of cerebral dopa decarboxylase (DDC) activity, secondary to antagonism of N-methyl-D-aspartate (NMDA) type glutamate receptors. We tested the specific hypothesis that amantadine
F Estelle R Simons et al.
The Journal of allergy and clinical immunology, 110(5), 777-783 (2002-11-06)
The extent of the distribution of H(1)- antihistamines into the skin and H(1)-antihistamine activity in the skin are clinically relevant in the treatment of allergic skin disorders. In a prospective, randomized, double-blind, parallel-group, multiple-dose study, we gave fexofenadine 180 mg
M Magerl et al.
The British journal of dermatology, 166(5), 1095-1099 (2012-01-17)
Cold urticaria is a rare but severe and potentially lethal condition. It is primarily treated symptomatically with H(1) -antihistamines. However, patients have a variable response to these drugs and, to date, it has not been possible to predict readily the
Mohamed El-Awady et al.
Journal of chromatography. A, 1309, 64-75 (2013-08-21)
The analysis of hydrophobic basic analytes by micellar electrokinetic chromatography (MEKC) is usually challenging because of the tendency of these analytes to be adsorbed onto the inner capillary wall in addition to the difficulty to separate these compounds as they

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service